<html>
<head>PUBMED IDs for ENOPH1</head>
<body bgcolor='#C5F0F2'><h1>ENOPH1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20522426/'>Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.</a> September 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913759/'>Expanding the spectrum of microdeletion 4q21 syndrome: a partial phenotype with incomplete deletion of the minimal critical region and a new association with cleft palate and Pierre Robin sequence.</a> March 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913758/'>Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.</a> May 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913756/'>Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.</a> June 21  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/27288323/'>A de novo microtriplication at 4q21.21-q21.22 in a patient with a vascular malignant hemangioma, elongated sigmoid colon, developmental delay, and absence of speech.</a> June 12  2016<br></body></html>
